Add BrightSurf on Google Email

Common heart failure drugs can be safely used at higher, more effective doses, study says

A new study published in the Archives of Internal Medicine shows that patients with heart failure can tolerate higher doses of ACE inhibitors without severe side effects. The research found that nearly all patients experienced only slight decreases in blood pressure and kidney function, which can be managed by adjusting the dose.

SourceUniversity of California - San Francisco·JournalArchives of Internal Medicine·DateJan 31, 2001

Calcium channel blockers not as effective as other drugs

Researchers found that calcium channel blockers (CCBs) were significantly less effective at preventing heart attacks, heart failure, and cardiovascular events compared to ACE inhibitors, beta-blockers, and diuretics. The study analyzed over 27,000 patients and showed a 26% higher risk of heart attack among CCB users.

SourceAtrium Health Wake Forest Baptist·JournalThe Lancet·DateDec 6, 2000
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Key heart drug underutilized

A Duke University Medical Center study found that ACE inhibitors are prescribed in just over half the cases they should be, despite clear evidence of their benefits. The study's author suggests increasing physician education and implementing an oversight system to ensure patients receive the best treatments.

SourceDuke University Medical Center·DateNov 12, 2000

Drugs found to protect the kidneys

A study by the NIH found that ACE inhibitors and beta blockers significantly reduced kidney failure risk compared to calcium channel blockers. High blood pressure management has improved stroke and heart disease risks, but kidney failure remains a concern for African Americans.

SourceNIH/National Institute of Diabetes and Digestive and Kidney Diseases·DateOct 12, 2000

Potent potential antibiotic found

Researchers at the University of Michigan have discovered a powerful new antibiotic candidate, PD 404182, which is 10,000 times more effective than other known inhibitors of a key enzyme in Gram-negative bacteria. The compound targets KDO 8-P synthase, essential for bacterial cell surface formation, and shows promise in weakening bacte...

SourceUniversity of Michigan·JournalJournal of the American Chemical Society·DateSep 10, 2000
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Chemical scissors may fine-tune nerve cell migration

Researchers discover that nerve cells use chemical scissors to clip off axon guidance receptors, controlling their navigation in the nervous system. Metalloprotease inhibitors enhance netrin activity by blocking receptor cleavage.

SourceHoward Hughes Medical Institute·JournalScience·DateAug 24, 2000

Experimental drug reverses effects of Fabry disease in mice

Researchers developed an experimental drug that reversed the effects of Fabry disease in mice, reducing glycolipid levels and eliminating toxic side effects. The treatment has potential applications for other lysosomal storage diseases affecting thousands of people in the US.

SourceUniversity of Michigan·JournalJournal of Clinical Investigation·DateJun 11, 2000

New drug shows promise for saving lives from heart failure

Omapatrilat, a vasopeptidase inhibitor, has been shown to improve cardiovascular function and reduce death rates and hospitalization for worsening heart failure. The drug may offer a potential breakthrough in treating congestive heart failure, which kills over 44,000 annually.

SourceAmerican Heart Association·DateNov 9, 1999
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Annals Of Internal Medicine - tip sheet for November 2, 1999

A study of 30 people with iron deficiency anemia found that curing Helicobacter pylori reversed the anemia. Meanwhile, researchers discovered that 51% of eligible elderly patients hospitalized with acute myocardial infarction did not receive early beta-blocker therapy, leading to higher in-hospital mortality rates.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateNov 1, 1999

Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Researchers at Thomas Jefferson University and Oxford University have found a promising drug against the hepatitis C virus (HCV), called N-nonyl-DNJ, which inhibits the activity of an important cellular enzyme, glucosidase. This drug may sidestep resistant viruses, a major problem with current treatments.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateOct 11, 1999

New findings point to new target to block angiogenesis

Scientists at Vanderbilt University Medical Center have identified a new target for drugs that inhibit tumor angiogenesis. Thromboxane A2 receptor antagonists show promise in blocking endothelial cell migration and preventing blood vessel formation associated with tumors.

SourceVanderbilt University Medical Center·JournalCancer Research·DateSep 15, 1999
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

New anti-angiogenic proteins discovered

Researchers at UCLA and Human Genome Sciences have discovered two human proteins, METH-1 and METH-2, that inhibit blood vessel formation and show promise in treating a range of cancer tumors. The proteins were found to be more potent than endostatin in preventing new blood vessel growth.

SourceHuman Genome Sciences, Inc.·JournalJournal of Biological Chemistry·DateAug 5, 1999

Details of promising cancer therapy shows for the first time

Researchers at Schering-Plough Research Institute have made the first atomic view of a promising new class of cancer-fighting drugs. The discovery may lead to faster, better refinement of the drugs and the development of more potent, less toxic treatments.

SourceAmerican Chemical Society·JournalJournal of Medicinal Chemistry·DateJun 1, 1999
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Doctors Are Underprescribing Key Blood Pressure Drug In Heart Attack Patients Most Likely To Benefit, Study Says

A national study finds that doctors are increasingly prescribing ACE inhibitors to heart attack patients, but still underprescribing them to those most in need. The study suggests that following American College of Cardiology guidelines could have saved up to 1,800 lives in the first year.

SourceUniversity of California - San Francisco·JournalJournal of the American College of Cardiology·DateJul 31, 1998

Old Drugs, New Tricks

Fibrates, used for decades to treat hyperlipidemia and atherosclerosis, have been shown to reduce inflammation in vascular muscle cells, inhibiting the production of pro-inflammatory cytokines. This mechanism suggests that fibrates may have a beneficial vascular action during atherosclerosis treatment.

SourceFrench National Institute for Health and Medical Research (INSERM)·JournalNature·DateJun 24, 1998
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Rapid Progress Reported On New Class Of Anti-Cancer Drugs

Researchers have made rapid progress on a new class of anti-cancer drugs that target the Ras protein activation pathway, which causes up to 90% of pancreatic cancers. Laboratory studies have shown effective inhibition of cancer cells using FTase inhibitors.

SourceDuke University·DateMar 30, 1998
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

MGH Study Finds Ace Inhibitors Underprescribed For Heart Failure

A recent MGH study found that only 31% of patients with heart failure were prescribed ACE inhibitors in 1994, despite their proven effectiveness in reducing death and disability. The study suggests a lack of knowledge and unrealistic assessments may contribute to the underprescription of these medications.

SourceMassachusetts General Hospital·JournalArchives of Internal Medicine·DateNov 24, 1997

Inhibiting Cell-Death Gene May Slow ALS Progression

A recent study found that inhibiting the ICE gene, responsible for programmed cell death, slowed ALS-like symptoms in mice. The research suggests that targeting this genetic pathway could lead to a new treatment option for patients with ALS.

SourceMassachusetts General Hospital·JournalNature·DateJul 2, 1997
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.